The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2023

Filed:

Oct. 28, 2021
Applicant:

Vast Sea Biotechnology, Inc., Rockville, MD (US);

Inventors:

Norman Zhennan Lai, N. Potomac, MD (US);

Yuebin Tan, Gaithersburg, MD (US);

Ying Wang, Washington, DC (US);

Assignee:

Vast Sea Biotechnology, Inc., Rockville, MD (US);

Attorney:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 38/48 (2006.01); A61K 31/375 (2006.01); A61K 31/4415 (2006.01); A61K 31/714 (2006.01); A61K 31/593 (2006.01); A61K 33/30 (2006.01); A61K 31/198 (2006.01); A61K 36/534 (2006.01); A61P 31/14 (2006.01); C12N 15/86 (2006.01); A23L 33/18 (2016.01); A61K 31/7088 (2006.01); A61K 38/55 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1131 (2013.01); A23L 33/18 (2016.08); A61K 31/198 (2013.01); A61K 31/375 (2013.01); A61K 31/4415 (2013.01); A61K 31/593 (2013.01); A61K 31/7088 (2013.01); A61K 31/714 (2013.01); A61K 33/30 (2013.01); A61K 36/534 (2013.01); A61K 38/4813 (2013.01); A61K 38/556 (2013.01); A61P 31/14 (2018.01); C12N 15/86 (2013.01); C12Y 304/17023 (2013.01); A23V 2002/00 (2013.01); A61K 48/00 (2013.01); C12N 2310/14 (2013.01); C12N 2310/321 (2013.01); C12N 2310/322 (2013.01); C12N 2310/3517 (2013.01); C12N 2320/32 (2013.01); C12N 2750/14143 (2013.01);
Abstract

This disclosure is directed to inhibitory oligonucleotides, inhibitory peptides, compositions and methods for preventing or treating Coronavirus disease 2019 (COVID-19). In one aspect, the disclosure is directed to compositions that comprise inhibitory oligonucleotides against one or more SARS-CoV-2 virus genes. In another aspect, the disclosure is directed to compositions that comprise inhibitory peptides that inhibit SARS-COV-2 entry into cells. Another aspect of the disclosure is directed to gene therapy methods for treating COVID-19, and vectors for carrying out the same. Finally, the disclosure provides nutritional supplements to support human immunity and prevent or inhibit viral infections.


Find Patent Forward Citations

Lai, Norman. (2023). Compositions and methods for treating covid-19 (U.S. Patent No. 11732264). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11732264

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…